Triphala, ayurvedic formulation for treating and preventing cancer: A review

Journal of Alternative and Complementary Medicine

Volumn 16, Issue 12, 2010, Pages 1301-1308

  Baliga, Manjeshwar Shrinath ^a  

^a FATHER MULLER MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMUTAGENIC AGENT; ANTINEOPLASTIC AGENT; AYURVEDIC DRUG; EMBLICA OFFICINALIS EXTRACT; FREE RADICAL; METHOTREXATE; TERMINALIA BELERICA EXTRACT; TERMINALIA CHEBULA EXTRACT; TRIPHALA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; AYURVEDA; CANCER PREVENTION; CHEMOPROPHYLAXIS; EMBLICA OFFICINALIS; HUMAN; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; RADIATION PROTECTION; REVIEW; TERMINALIA BELERICA; TERMINALIA CHEBULA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; HUMANS; MEDICINE, AYURVEDIC; NEOPLASMS; PHYLLANTHUS EMBLICA; PHYTOTHERAPY; PLANT EXTRACTS; TERMINALIA;

EID: 78650162192     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2009.0633     Document Type: Review

References (62)

1. WCRF/AICR. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: AICR 2007.
2. DeVita VT, Lawrence TS, Hellman S, Rosenberg SA. Cancer: Principles & Practice of Oncology, 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2004.
3. Hall EJ. Radiobiology for the Radiologist. 5th ed. Philadelphia: Lippincott, Williams & Wilkins, 2005.
4. Joshi H, Parle M. Brahmi rasayana improves learning and memory in mice. eCAM 2006;3:79-85. (Pubitemid 43999655)
5. Mahdihassan S. The tradition of alchemy in India. Am J Chin Med 1981;9:23-33.
6. Kulkarni RD. Principles of Pharmacology in Ayurveda. Mumbai, India: Ram Sangam Graphics, 1997.
7. Mahdihassan S. Indian Alchemy or Rasayana in the Light of Ascetism and Geriatrics. Delhi, India: Motital Banarsidass Publishers, 1991.
8. Sharma RK, Dash B. Carka Samhita Volume II. Varanasi, India: Chowkamba Sanskrit Series Office, 1998.
9. Singh K. Concept of Ojas and the effect of Rasayanas in the management of cancer. Proceedings of Ayurveda Seminar on Cancer, Thrissur, India. 1990:15-18.
10. Puri HS. Rasayana: Ayurvedic Herbs of Rejuvenation and Longevity. London: Taylor & Francis, 2003.
11. Tripathi YB, Tripathi P, Arjmandi BH. Nutraceuticals and cancer management. Front Biosci 2005;10:1607-1618.
12. Nadkarni AK. Indian Materia Medica, 3rd ed. Mumbai, India: Popular Press Ltd., 1976.
13. Kaviratna AC, Sharma P. Caraka Samhita, Vols. 1-4. Delhi, India: Sri Satguru Publications, 1996
14. Anonymous. The Ayurvedic Formulary of India, Part I, 2nd ed. New Delhi: Department of ISM and H, Ministry of Health and Family Welfare, Government of India, 2003.
15. Nariya M, Shukla V, Jain S, Ravishankar B. Comparison of enteroprotective efficacy of triphala formulations (Indian Herbal Drug) on methotrexate-induced small intestinal damage in rats. Phytother Res 2009;23:1092-1098.
16. Rastogi RP, Mehrotra BN. Compendium of Indian Medicinal Plants, Vol. 1-3. New Delhi, India: Publications and Information Directorate, 1993.
17. Mukherjee PK, Rai S, Bhattacharya S, et al. Clinical studies of " triphala": A well known phytomedicine from India. Iran J Pharmacol Therapeut 2006;5:51-54.
18. Jagetia GC, Baliga MS, Malagi KJ, Sethukumar Kamath M. The evaluation of the radioprotective effect of triphala (an Ayurvedic rejuvenating drug) in the mice exposed to gamma-radiation. Phytomedicine 2002;9:99-108.
19. Jagetia GC, Malagi KJ, Baliga MS, et al. Triphala, an Ayur-vedic rasayana drug, protects mice against radiation-induced lethality by free-radical scavenging. J Altern Complement Med 2004;10:971-978.
20. Kaur S, Michael H, Arora S, et al. The in vitro cytotoxic and apoptotic activity of Triphala: An Indian herbal drug. J Eth-nopharmacol 2005;97:15-20.
21. Sandhya T, Lathika KM, Pandey BN, Mishra KP. Potential of traditional Ayurvedic formulation, triphala, as a novel anti-cancer drug. Cancer Lett 2006;231:206-214.
22. Shi Y, Sahu RP, Srivastava SK. Triphala inhibits both in vitro and in vivo xenograft growth of pancreatic tumor cells by inducing apoptosis. BMC Cancer 2008;8:294.
23. Sandhya T, Mishra KP. Cytotoxic response of breast cancer cell lines, MCF-7 and T 47 D to triphala and its modification by antioxidants. Cancer Lett 2006;238:304-313.
24. Taminiau JA, Gall DG, Hamilton JR. Response of the rat small-intestine epithelium to methotrexate. Gut 1980;21:486-492.
25. Arora R, Gupta D, Chawla R, et al. Radioprotection by plant products: Present status and future prospects. Phytother Res 2005;19:1-22.
26. Sandhya T, Lathika KM, Pandey BN, et al. Protection against radiation oxidative damage in mice by triphala. Mutat Res 2006;609:17-25.
27. Deep G, Dhiman M, Rao AR, Kale RK. Chemopreventive potential of triphala (a composite Indian drug) on benzo(a)-pyrene induced forestomach tumorigenesis in murine tumor model system. J Exp Clin Cancer Res 2005;24:555-563.
28. Vani T, Rajani M, Sarkar S, Shishoo CJ. Antioxidant properties of the Ayurvedic formulation Triphala and its constituents. Int J Pharmacogn 1997;35:313-317.
29. Naik GH, Priyadarsini KI, Bhagirathi RG, et al. In vitro an-tioxidant studies and free radical reactions of triphala, an Ayurvedic formulation and its constituents. Phytother Res 2005;19:582-586.
30. Jagetia GC, Rao SK, Baliga MS, Babu K. The evaluation of nitric oxide scavenging activity of certain herbal formulations in vitro: A preliminary study. Phytother Res 2004;18: 561-565.
31. Sabu MC, Kuttan R. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol 2003;8:155-160.
32. Rasool M, Sabina EP. Antiinflammatory effect of the Indian Ayurvedic herbal formulation triphala on adjuvant-induced arthritis in mice. Phytother Res 2007;21:889-894.
33. Kaur S, Arora S, Kaur K, Kumar S. The in vitro anti-mutagenic activity of Triphala: An Indian herbal drug. Food Chem Toxicol 2002;40:527-534.
34. Srikumar R, Jeya Parthasarathy N, Sheela Devi R. Im-munomodulatory activity of triphala on neutrophil functions. Biol Pharm Bull 2005;28:398-403.
35. Srikumar R, Parthasarathy NJ, Manikandan S, et al. Effect of triphala on oxidative stress and on cell-mediated immune response against noise stress in rats. Mol Cell Biochem 2006;283:67-74.
36. Suresh K, Vasudevan DM. Augmentation of murine natural killer cell and antibody dependent cellular cytotoxicity activities by Phyllanthus emblica, a new immunomodulator. J Ethnopharmacol 1994;44:55-60.
37. Jose JK, Kuttan G, Kuttan R. Antitumour activity of Emblica officinalis. J Ethnopharmacol 2001;75:65-69.
38. Rajeshkumar NV, Pillai MR, Kuttan R. Induction of apo-ptosis in mouse and human carcinoma cell lines by Emblica officinalis polyphenols and its effect on chemical carcino-genesis. J Exp Clin Cancer Res 2003;22:201-212.
39. Lambertini E, Piva R, Khan MT, et al. Effects of extracts from Bangladeshi medicinal plants on in vitro proliferation of human breast cancer cell lines and expression of estrogen receptor alpha gene. Int J Oncol 2004;24:419-423.
40. Khan MT, Lampronti I, Martello D, et al. Identification of pyrogallol as an antiproliferative compound present in extracts from the medicinal plant Emblica officinalis: Effects on in vitro cell growth of human tumor cell lines. Int J Oncol 2002;21:187-192.
41. Yang CJ, Wang CS, Hung JY, et al. Pyrogallol induces G2-M arrest in human lung cancer cells and inhibits tumor growth in an animal model. Lung Cancer 2009;66:162-168.
42. Zhang YJ, Nagao T, Tanaka T, et al. Antiproliferative activity of the main constituents from Phyllanthus emblica. Biol Pharm Bull 2004;27:251-255.
43. Saleem A, Husheem M, Härkönen P, Pihlaja K. Inhibition of cancer cell growth by crude extract and the phenolics of Terminalia chebula retz. fruit. J Ethnopharmacol 2002;81: 327-336.
44. Reddy DB, Reddy TC, Jyotsna G, et al. Chebulagic acid, a COX-LOX dual inhibitor isolated from the fruits of Termi-nalia chebula Retz., induces apoptosis in COLO-205 cell line. J Ethnopharmacol 2009;124:506-512.
45. Haque R, Bin-Hafeez B, Ahmad I, et al. Protective effects of Emblica officinalis Gaertn. in cyclophosphamide-treated mice. Hum Exp Toxicol 2001;20:643-650.
46. Sharma N, Trikha P, Athar M, Raisuddin S. Inhibitory effect of Emblica officinalis on the in vivo clastogenicity of ben-zo[a]pyrene and cyclophosphamide in mice. Hum Exp Toxicol 2000;19:377-384.
47. Singh I, Sharma A, Nunia V, Goyal PK. Radioprotection of Swiss albino mice by Emblica officinalis. Phytother Res 2005; 19:444-446.
48. Hari Kumar KB, Sabu MC, Lima PS, Kuttan R. Modulation of haematopoetic system and antioxidant enzymes by Emblica officinalis Gaertn. and its protective role against gamma-radiation induced damages in mice. J Radiat Res 2004;45:549-555.
49. Singh I, Soyal D, Goyal PK. Emblica officinalis (Linn.) fruit extract provides protection against radiation-induced he-matological and biochemical alterations in mice. J Environ Pathol Toxicol Oncol 2006;25:643-654.
50. Jindal A, Soyal D, Sharma A, Goyal PK. Protective effect of an extract of Emblica officinalis against radiation-induced damage in mice. Integr Cancer Ther 2009;8:98-105.
51. Naik GH, Priyadarsini KI, Naik DB, et al. Studies on the aqueous extract of Terminalia chebula as a potent antioxidant andaprobable radioprotector. Phytomedicine 2004;11:530-538.
52. Gandhi NM, Nair CK. Radiation protection by Terminalia chebula: Some mechanistic aspects. Mol Cell Biochem 2005; 277:43-48.
53. Sancheti G, Jindal A, Kumari R, Goyal PK. Chemopreventive action of Emblica officinalis on skin carcinogenesis in mice. Asian Pac J Cancer Prev 2005;6:197-201.
54. Sultana S, Ahmed S, Sharma S, Jahangir T. Emblica officinalis reverses thioacetamide-induced oxidative stress and early promotional events of primary hepatocarcinogenesis. J Pharm Pharmacol 2005;56:1573-1579.
55. Sultana S, Ahmed S, Jahangir T. Emblica officinalis and he-patocarcinogenesis: A chemopreventive study in Wistar rats. J Ethnopharmacol 2008;118:1-6.
56. Niture SK, Rao US, Srivenugopal KS. Chemopreventative strategies targeting the MGMT repair protein: Augmented expression in human lymphocytes and tumor cells by etha-nolic and aqueous extracts of several Indian medicinal plants. Int J Oncol 2006;29:1269-1278.
57. Mir AI, Kumar B, Tasduq SA, et al. Reversal of hepatotoxin-induced pre-fibrogenic events by Emblica officinalis: A his-tological study. Indian J Exp Biol 2007;45:626-629.
58. Nandi P, Talukder G, Sharma A. Dietary chemoprevention of clastogenic effects of 3, 4-benzo(a)pyrene by Emblica officinalis Gaertn. fruit extract. Br J Cancer 1997;76:1279-1283.
59. Banu SM, Selvendiran K, Singh JP, Sakthisekaran D. Protective effect of Emblica officinalis ethanolic extract against 7,12-dimethylbenz(a)anthracene (DMBA) induced geno-toxicity in Swiss albino mice. Hum Exp Toxicol 2004;23:527-531.
60. Sharma N, Trikha P, Athar M, Raisuddin S. In vitro inhibition of carcinogen-induced mutagenicity by Cassia occi-dentalis and Emblica officinalis. Drug Chem Toxicol 2000;23: 477-484.
61. Prasad L, Husain Khan T, Jahangir T, Sultana S. Chemo-modulatory effects of Terminalia chebula against nickel chloride induced oxidative stress and tumor promotion response in male Wistar rats. J Trace Elem Med Biol 2006; 20:233-239.
62. Prasad L, Khan TH, Jahangir T, Sultana S. Abrogation of DEN/Fe-NTA induced carcinogenic response, oxidative damage and subsequent cell proliferation response by Terminalia chebula in kidney of Wistar rats. Pharmazie 2007;62:790-797.